Population
1,000 patients in whom a transvenous pacemaker had been implanted
Design
Cohort
Follow-up
up to one year
Authors
Loading...
Rare SVC syndrome after pacemaker implantation may respond to anticoagulation; leaves open need for larger prospective studies on incidence and prevention.
Superior vena cava syndrome is a rare complication of transvenous pacemaker implantation (occurring in 0.4% of patients) that can be effectively managed with anticoagulation.
Chamorro et al. (1978) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: